mutations known passenger mutations appear unimportant seemingly ride knows driver mutations needed promote different kinds cancers study determined average tumor requires driver mutations studies found tumors frequently contain 20 driver mutations despite difficulties figuring genetic mutations important given tumor researchers began making progress targeting specific cancer mutations late 1990s treatments imatinib mesylate brand gleevec undermines common driver chronic myeloid leukemia trastuzumab brand herceptin addresses mutation responsible quarter breast cancers customized therapies soon followed past years patients lung cancer routinely tested abnormality gene known 7 percent patients genetic mistake melds gene gene yields abnormal protein drives tumor growth drugs block mutant